person · Reporting owner

SINNOTT ROBERT A

Disclosed activity across 1 company

Tapewire entity: 93520
SEC CIK: 0001298819

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
USANA HEALTH SCIENCES INCUSNA · Entity 6114	CHIEF SCIENTIFIC OFFICER	March 05, 2024	March 05, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

USANA HEALTH SCIENCES INC

Report date March 05, 2024 · Filed March 05, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2024-03-05 transaction · row 1 1 source row Row 1 · 2024-03-05 · Sale · Disposed 3,945 · Balance 0 F1: Weighted average price $46.555. Price range in multiple transactions was $46.4801 to $46.65 inclusively.

Filing footnotes · ownership attribution and instrument terms

F1: Weighted average price $46.555. Price range in multiple transactions was $46.4801 to $46.65 inclusively.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 16, 2018 Filed Aug 20, 2018 17:46 UTC	USANA HEALTH SCIENCES INC USNA · Entity 6114	Exercise / conversionStock-Settles Stock appreciation Right · Derivative	14,645	$0.00 Strike: $65.48	$0.00	Disclosure SEC source: 0001179110-18-010698 · edgar.xml · derivative · entry 5 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,355 Underlying: Common Stock · 14,645 shares Expires 2022-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 16, 2018 Filed Aug 20, 2018 17:46 UTC	USANA HEALTH SCIENCES INC USNA · Entity 6114	SaleCommon Stock	7,211	$129.39	$932,998.84	Disclosure SEC source: 0001179110-18-010698 · edgar.xml · nonDerivative · entry 2 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price. Price range in multiple transactions was $129.00 to $129.90, inclusive. Read SEC document
August 16, 2018 Filed Aug 20, 2018 17:46 UTC	USANA HEALTH SCIENCES INC USNA · Entity 6114	Exercise / conversionCommon Stock	7,211	$65.48	$472,176.28	Disclosure SEC source: 0001179110-18-010698 · edgar.xml · nonDerivative · entry 1 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II Read SEC document
February 05, 2018 Filed Feb 7, 2018 22:39 UTC	USANA HEALTH SCIENCES INC USNA · Entity 6114	GrantRestricted Stock Units · Derivative	5,153	$0.00	$0.00	Disclosure SEC source: 0001179110-18-001745 · edgar.xml · derivative · entry 1 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,462 Underlying: Common Stock · 5,153 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document
November 29, 2017 Filed Dec 1, 2017 19:40 UTC	USANA HEALTH SCIENCES INC USNA · Entity 6114	Exercise / conversionStock-Settles Stock appreciation Right · Derivative	30,000	$0.00 Strike: $65.48	$0.00	Disclosure SEC source: 0001179110-17-014761 · edgar.xml · derivative · entry 3 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 30,000 shares Expires 2022-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 29, 2017 Filed Dec 1, 2017 19:40 UTC	USANA HEALTH SCIENCES INC USNA · Entity 6114	SaleCommon Stock	2,716	$72.00	$195,552.00	Disclosure SEC source: 0001179110-17-014761 · edgar.xml · nonDerivative · entry 2 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document
November 29, 2017 Filed Dec 1, 2017 19:40 UTC	USANA HEALTH SCIENCES INC USNA · Entity 6114	Exercise / conversionCommon Stock	2,716	$65.48	$177,843.68	Disclosure SEC source: 0001179110-17-014761 · edgar.xml · nonDerivative · entry 1 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II Read SEC document
October 23, 2017 Filed Oct 25, 2017 20:42 UTC	USANA HEALTH SCIENCES INC USNA · Entity 6114	GrantRestricted Stock Units · Derivative	2,309	$0.00	$0.00	Disclosure SEC source: 0001179110-17-013432 · edgar.xml · derivative · entry 1 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,309 Underlying: Common Stock · 2,309 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.